"Chemokine CXCL10" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CXC chemokine that is induced by GAMMA-INTERFERON and is chemotactic for MONOCYTES and T-LYMPHOCYTES. It has specificity for the CXCR3 RECEPTOR.
| Descriptor ID |
D054357
|
| MeSH Number(s) |
D12.644.276.374.200.120.500 D12.776.467.374.200.120.500 D23.125.300.120.500 D23.469.200.120.500 D23.529.374.200.120.500
|
| Concept/Terms |
Chemokine CXCL10- Chemokine CXCL10
- CXCL10, Chemokine
- Cytokine IP-10 Protein
- Cytokine IP 10 Protein
- IP-10 Protein, Cytokine
- Interferon-Inducible Protein 10
- Interferon Inducible Protein 10
- CXC Chemokine IP-10
- CXC Chemokine IP 10
- Chemokine IP-10, CXC
- Small Inducible Cytokine B10
- IFN-gamma-Inducible Protein, 10 kDa
- IFN gamma Inducible Protein, 10 kDa
- CXCL10 Chemokine
- Chemokine, CXCL10
- gammaIP-10 Protein
- gammaIP 10 Protein
- Chemokine (C-X-C Motif) Ligand 10
- Interferon-gamma-Inducible Protein of 10 kDa
- Interferon gamma Inducible Protein of 10 kDa
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL10".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL10".
This graph shows the total number of publications written about "Chemokine CXCL10" by people in this website by year, and whether "Chemokine CXCL10" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CXCL10" by people in Profiles.
-
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat Med. 2014 Nov; 20(11):1301-9.
-
In situ profiling of adipokines in subcutaneous microdialysates from lean and obese individuals. Am J Physiol Endocrinol Metab. 2008 Nov; 295(5):E1095-105.
-
Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol. 2006 Sep; 26(9):2147-52.
-
Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes. 2005 Dec; 54 Suppl 2:S11-7.
-
Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler Thromb Vasc Biol. 2006 Jan; 26(1):194-9.
MeSH information
